Detection of microvesicle miRNA expression in ALL subtypes and analysis of their functional roles

Abstract

Microvesicles (MVs) are the heterogeneous mixtures of vesicles. MVs released by leukemia cells constitute an important part of the leukemia microenvironment. MVs might act as important reservoirs of microRNAs (miRNAs). It is worth evaluating whether MVs possess some unique miRNA contents that are valuable in understanding the pathogenesis. In this study, we investigated the miRNA expression patterns of Nalm-6-derived MVs, Jurkat-derived MVs and normal cell-derived MVs using miRNA microarrays. The potential target genes regulated by differentially expressed miRNAs were also predicted and analyzed. Results demonstrated that 182 miRNAs and 166 miRNAs were differentially expressed in Nalm-6-MVs and Jurkat-MVs, respectively. Many oncogenes, tumor suppressors and signal pathway genes were targeted by these aberrantly expressed miRNAs, which might contribute to the development of B-ALL or T-ALL. Our findings expanded the potential diagnostic markers of ALL and provided useful information for ALL pathogenesis.

Keywords

microvesicles / miRNA expression profiles / acute lymphoblastic leukemia subtypes

References

[1] ZwaalRF, SchroitAJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood, 1997, 89(4): 1121-1132

[2] HolmePA, OrvimU, HamersMJ, et al.. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol, 1997, 17(4): 646-653

[3] AupeixK, HugelB, MartinT, et al.. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest, 1997, 99(7): 1546-1554

[4] RatajczakJ, WysoczynskiM, HayekF, et al.. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia, 2006, 20(9): 1487-1495

[5] Baj-KrzyworzekaM, SzatanekR, WeglarczykK, et al.. Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett, 2007, 113(2): 76-82

[6] BartelDP. MiRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297

[7] LuJ, GetzG, MiskaEA, et al.. MiRNA expression profiles classify human cancers. Nature, 2005, 354(7043): 834-838

[8] ValadiH, EkstromK, BossiosA, et al.. Exosome-mediated transfer of mRNAs and MiRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 2007, 9(6): 654-659

[9] RowleyJD. Molecular genetics in acute leukemia. Leukemia, 2000, 14(3): 513-517

[10] ThielE, KranzBR, RaghavacharA. Prethymic phenotype and genotype of pre-T(CD7+/ER−)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood, 1989, 73(5): 1247-1258

[11] ZhouB, WangS, MayrC, et al.. miR-150, a miRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A, 2007, 104(17): 7080-7085

[12] MartínezMC, LarbretF, ZobairiF, et al.. Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood, 2006, 108(9): 3012-3020

[13] ZhangZK, DaviesKP, AllenJ. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol, 2002, 22(16): 5975-5988

[14] Le BacconP, LerouxD, DascalescuC, et al.. Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma. Genes Chromosomes Cancer, 2001, 32(3): 250-264

[15] NagelS, VenturiniL, PrzybylskiGK, et al.. Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymphoma, 2009, 50(1): 101-108

[16] MolitorisJK, McCollKS, DistelhorstCW. Glucocorticoid-mediated repression of the oncogenic MiRNA cluster miR-17∼92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol, 2011, 25(3): 409-420

[17] GrillariJ, HacklM, Grillari-VoglauerR. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology, 2010, 11(4): 501-506

[18] Martinez-DelgadoB, MeléndezB, CuadrosM, et al.. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res, 2004, 10(15): 4971-4982

[19] BouilletP, PurtonJF, GodfreyDI. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature, 2002, 415(6874): 922-926

[20] GlittenbergM, LigoxygakisP. CYLD: a multifunctional deubiquitinase. Fly (Austin), 2007, 1(6): 330-332

[21] KraszewskaMD, DawidowskaM, KosmalskaM. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients. Blood Cells Mol Dis, 2013, 50(1): 33-38

[22] GiambraV, JenkinsCR, WangH. NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nat Med, 2012, 18(11): 1693-1698.

[23] JohnstoneRM. Exosomes biological significance: A concise review. Blood Cells Mol Dis, 2006, 36(2): 315-321

[24] SassenS, MiskaEA, CaldasC. MiRNA: implications for cancer. Virchows Arch, 2008, 452(1): 1-10

[25] ZhuYD, WangL, SunC, et al.. Distinctive MiRNA signature is associated with the diagnosis and prognosis of acute leukemia. Med Oncol, 2012, 29(4): 2323-2331

[26] ZhangY, LiaoJM, ZengSX, et al.. p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep, 2011, 12(8): 811-817

[27] PiepoliA, TavanoF, CopettiM, et al.. miRNA expression profiles identify drivers in colorectal and pancreatic cancers. PLoS One, 2012, 7(3): e33663